Search

The bioinorganic complex of aspartic acid and arsenic triiodide was synthesized by a solid-state reaction at room temperature. The formula of the complex is AsI3[HOOCCH2CH(NH2)COOH]2.5. The crystal structure of the complex belongs to monoclinic system with lattice parameters: a=1.0019 nm, b=1.5118 nm, c=2.1971 nm, and β=100.28°. The infrared spectra can demonstrate the complex formation between the arsenic ion and aspartic acid, and the complex may be a dimer with bridge structure. The result of primary biological test indicates that the complex possesses better biological activity for the HL-60 cells of the leukemia than arsenic triiodide.

Nickel(II) acetate tetrahydrate was treated with the ligand CH2(H2sal-sbdt)2 in methanol heated at reflux to yield a novel binuclear Ni(II) nanorod complex of the formula CH2{Ni(II)(sal-sbdt)(H2O)}2. The ligand of CH2(H2sal-sbdt)2 was derived from 5,5′-methylene-bissalicylaldehyde and S-benzyldithiocarbazate. The complex was characterized by elemental analysis, UV-Vis, FT-IR spectra, thermal analysis (TG-DSC), and scanning electron microscopy (SEM). The nickel(II) was coordinated by imino nitrogen, thiolato sulfur, and phenolic oxygen from the Schiff base ligand, and oxygen from the coordinated water, respectively. The pyrolysis reactions in the thermal decomposition process of the complex, the experimental, and calculated percentage mass loss were also given. The Ni(II) complex belonged to nanocrystalline metal complex, and the average size of the nanorod complex was about 30 nm × 150 nm. The antibacterial activities were screened for the Schiff base ligand and the Ni(II) nanorod complex against four bacteria: Staphylococcus aureus, Escherichia coli, Bacillus subtilis, and Staphylococcus epidermidis. Both the ligand of CH2(H2sal-sbdt)2 and the Ni(II) complex had the most intense antibacterial activities against Escherichia coli.